Abu Dhabi [UAE], Department of Health Abu Dhabi (DoH) and M42 have collaborated to launch Abu Dhabi Biobank, the region's largest hybrid cord blood bank, as a leading destination for life sciences. This is its first offering. Strengthens the position of the emirate. The initiative aims to reduce waiting time for treatment, increase medical access for patients, improve survival rates and reduce the economic burden on governments. Announced at the opening of Abu Dhabi Global Healthcare Week 2024, where M42i Foundation is participating as a partner, Abu Dhabi Biobank is a unique global biobanking hub that provides invaluable data assets for maximum impact on people's health. It will be a key pillar of health transformation and aims to deliver excellence by building diverse, foundational, bio-assets that support therapeutics.Leading the way in life sciences research, medical innovation, new drug discovery and disease prevention with the goal of providing the highest standards of care. Personalized precision and preventive health care for all. The service will be launched across four key health institutions committed to maternal and child health in Abu Dhabi. Intending parents can avail this service at Danat Al Emarat Hospital for Women and Children, Cornish Hospital, Kanad Hospital and partner hospitals of the M42 Group. Noura Khamis Al Ghaithi, Undersecretary of NMC Healthcare, DOH, said through the biobank.The biological and medical data collected will inspire scientific breakthroughs, accelerate drug discovery, thereby contributing to the emirate's ability to find solutions to local and global health challenges. With an emphasis on cord-derived stem cells, this will have a significant impact on clinical care and patient outcomes. therapy and enabling local stem cell therapy delivery. He added, “Abu Dhabi Biobank’s ability to link umbilical cord blood, tissue, stem cells and a wide range of normal and pathological human samples with established large genomic, proteomics and clinical records will enable transformational and cutting-edge initiatives.” Sets the stage. A significant advancement for the country's health ecosystem, Abu Dhabi Biobank's cord blood donation will enable better care outcomes, building the country's regional self-reliance in research and innovation to meet the urgent need for cord blood stem cells.Stem cells act like a 'bio repair kit', helping to heal, restore and replenish other cells, which can be used for certain treatments. With the capacity to store 100,000 cord blood samples and five million pan-HUMA samples, the biobank houses a rich, diverse dataset of hematological and immune system disorders, such as leukemia, lymphoma and bone marrow diseases that require transplantation. Which will allow reads and can provide better matching globally. Haemopoietic stem cells. It aims to enhance the well-being of the community through preventive measures and access to advanced, high-quality health services.Abu Dhabi Biobank's cord blood bank facility, located at the Omics Center of Excellence in M42, is equipped with state-of-the-art automated technology and the best large capacity biobanking infrastructure. This infrastructure will safely preserve the samples, making them viable for research for clinical use for up to 30 years. Preserving your baby's cord blood by choosing a safe, painless and non-intrusive procedure can save lives and help build a healthy nation. They will have the opportunity to preserve stem cells, a part of public or private banking.